Cargando…
Insights from nanomedicine into chloroquine efficacy against COVID-19
Chloroquine — an approved malaria drug — is known in nanomedicine research for the investigation of nanoparticle uptake in cells, and may have potential for the treatment of COVID-19.
Autores principales: | Hu, Tony Y., Frieman, Matthew, Wolfram, Joy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094976/ https://www.ncbi.nlm.nih.gov/pubmed/32203437 http://dx.doi.org/10.1038/s41565-020-0674-9 |
Ejemplares similares
-
RETRACTED: Chloroquine or hydroxychloroquine for
COVID-19: why might they be hazardous?
por: Funck-Brentano, Christian, et al.
Publicado: (2020) -
Nanomedicine Reformulation of Chloroquine and Hydroxychloroquine
por: Stevens, David M., et al.
Publicado: (2020) -
Use of chloroquine in viral diseases
por: Savarino, Andrea
Publicado: (2011) -
Do we have enough evidence to use chloroquine/hydroxychloroquine as a public health panacea for COVID-19?
por: Palmeira, Vitória Andrade, et al.
Publicado: (2020) -
The need for robust characterization of nanomaterials for nanomedicine applications
por: Mahmoudi, Morteza
Publicado: (2021)